Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Diffusion-Weighted MRI in Intrahepatic Bile Duct Adenoma Arising from the Cirrhotic Liver

  • An, Chansik (Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Park, Sumi (Department of Radiology, National Health Insurance Corporation Ilsan Hospital) ;
  • Choi, Yoon Jung (Department of Pathology, National Health Insurance Corporation Ilsan Hospital)
  • Received : 2013.04.18
  • Accepted : 2013.05.12
  • Published : 2013.09.01
⟨ Previous Next ⟩

Abstract

A 64-year-old male patient with liver cirrhosis underwent a CT study for hepatocellular carcinoma surveillance, which demonstrated a 1.4-cm hypervascular subcapsular tumor in the liver. On gadoxetic acid-enhanced MRI, the tumor showed brisk arterial enhancement and persistent hyperenhancement in the portal phase, but hypointensity in the hepatobiliary phase. On diffusion-weighted MRI, the tumor showed an apparent diffusion coefficient twofold greater than that of the background liver parenchyma, which suggested that the lesion was benign. The histologic diagnosis was intrahepatic bile duct adenoma with alcoholic liver cirrhosis.

Keywords

References

  1. Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996;20:858-864 https://doi.org/10.1097/00000478-199607000-00009
  2. Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, fascicle 25. Washington DC: Armed Forces Institute of Pathology, 1958:19-29
  3. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, 2nd series. fascicle 26. Washington DC: Armed Forces Institute of Pathology, 1990:56-62
  4. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol 1988;12:708-715 https://doi.org/10.1097/00000478-198809000-00007
  5. Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol 2005;29:381-389 https://doi.org/10.1097/01.pas.0000149710.01559.fe
  6. Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, et al. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol 2011;12:403-415 https://doi.org/10.3348/kjr.2011.12.4.403
  7. Tajima T, Honda H, Kuroiwa T, Yoshimitsu K, Irie H, Aibe H, et al. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. J Comput Assist Tomogr 1999;23:690-695 https://doi.org/10.1097/00004728-199909000-00008
  8. Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, et al. Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol 2010;11:560-565 https://doi.org/10.3348/kjr.2010.11.5.560
  9. Koga F, Tanaka H, Takamatsu S, Baba S, Takihara H, Hasegawa A, et al. A case of very large intrahepatic bile duct adenoma followed for 7 years. World J Clin Oncol 2012;3:63-66 https://doi.org/10.5306/wjco.v3.i4.63
  10. Maeda E, Uozumi K, Kato N, Akahane M, Inoh S, Inoue Y, et al. Magnetic resonance findings of bile duct adenoma with calcification. Radiat Med 2006;24:459-462 https://doi.org/10.1007/s11604-006-0044-z
  11. Honda H, Onitsuka H, Yasumori K, Hayashi T, Ochiai K, Gibo M, et al. Intrahepatic peripheral cholangiocarcinoma: twophased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 1993;17:397-402 https://doi.org/10.1097/00004728-199305000-00011
  12. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104
  13. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254:47-66 https://doi.org/10.1148/radiol.09090021
  14. Feuerlein S, Pauls S, Juchems MS, Stuber T, Hoffmann MH, Brambs HJ, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol 2009;193:1070-1076 https://doi.org/10.2214/AJR.08.2093
  15. Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008;28:691-697 https://doi.org/10.1002/jmri.21467
  16. Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-bvalue diffusion-weighted imaging to distinguish welldifferentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 2011;197:W868-W875 https://doi.org/10.2214/AJR.10.6237
  17. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010;34:506-512 https://doi.org/10.1097/RCT.0b013e3181da3671
  18. Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009;30:1005-1011 https://doi.org/10.1002/jmri.21931
  19. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusionweighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008;18:486-492 https://doi.org/10.1007/s00330-007-0798-4
  20. Heo SH, Jeong YY, Shin SS, Kim JW, Lim HS, Lee JH, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol 2010;11:295-303 https://doi.org/10.3348/kjr.2010.11.3.295
  21. Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, et al. Diagnosis of liver fibrosis and cirrhosis with diffusionweighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 2010;195:671-676 https://doi.org/10.2214/AJR.09.3448
  22. Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007;46:658-665 https://doi.org/10.1002/hep.21747
  23. Mwangi I, Hanna RF, Kased N, Malek P, Shiehmorteza M, Wolfson T, et al. Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol 2010;194:1515-1522 https://doi.org/10.2214/AJR.09.3484

Cited by

  1. RE: Diffusion-Weighted MRI in Intrahepatic Bile Duct Adenoma Arising from the Cirrhotic Liver vol.15, pp.3, 2014, https://doi.org/10.3348/kjr.2014.15.3.401
  2. Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI vol.21, pp.2, 2013, https://doi.org/10.3350/cmh.2015.21.2.187
  3. Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein vol.21, pp.4, 2015, https://doi.org/10.3350/cmh.2015.21.4.393
  4. Magnetic Resonance Imaging Findings of Intrahepatic Bile Duct Adenoma: A Report of 4 Cases vol.39, pp.5, 2015, https://doi.org/10.1097/rct.0000000000000286
  5. Technical advancements and protocol optimization of diffusion-weighted imaging (DWI) in liver vol.41, pp.1, 2013, https://doi.org/10.1007/s00261-015-0602-x
  6. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma vol.29, pp.9, 2013, https://doi.org/10.1007/s00330-019-06030-0
  7. Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls vol.45, pp.11, 2013, https://doi.org/10.1007/s00261-020-02560-0